Cigna Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-788
Closed -$261K 590
2022
Q1
$261K Sell
788
-261
-25% -$80.3K 0.03% 489
2021
Q4
$377K Sell
1,049
-430
-29% -$145K 0.03% 448
2021
Q3
$482K Sell
1,479
-20
-1% -$6.78K 0.04% 431
2021
Q2
$468K Sell
1,499
-187
-11% -$57.4K 0.03% 445
2021
Q1
$537K Buy
1,686
+24
+1% +$7.68K 0.04% 429
2020
Q4
$539K Buy
1,662
+123
+8% +$34K 0.04% 392
2020
Q3
$426K Sell
1,539
-20
-1% -$5.76K 0.04% 387
2020
Q2
$378K Buy
+1,559
New +$313K 0.04% 471
2020
Q1
Sell
-1,259
Closed -$234K 670
2019
Q4
$234K Sell
1,259
-118
-9% -$21.9K 0.02% 585
2019
Q3
$286K Hold
1,377
0.03% 545
2019
Q2
$383K Buy
1,377
+21
+2% +$5.57K 0.04% 456
2019
Q1
$388K Hold
1,356
0.04% 450
2018
Q4
$440K Buy
1,356
+14
+1% +$4.86K 0.04% 374
2018
Q3
$458K Sell
1,342
-100
-7% -$39.4K 0.04% 393
2018
Q2
$589K Sell
1,442
-164
-10% -$59.4K 0.04% 373
2018
Q1
$466K Hold
1,606
0.03% 480
2017
Q4
$300K Sell
1,606
-129
-7% -$24.1K 0.02% 690
2017
Q3
$293K Buy
1,735
+108
+7% +$16.3K 0.02% 674
2017
Q2
$233K Sell
1,627
-131
-7% -$17.6K 0.02% 725
2017
Q1
$220K Buy
+1,758
New +$204K 0.02% 684

Other funds holding ABMD

Cigna Investments's ABMD Position: Q2 2022 in Review

Cigna Investments sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 788 shares — an estimated $261K sold.

Cigna Investments first reported a position in ABMD in Q1 2017 and held it in 20 quarters. The position peaked at $589K in Q2 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Cigna Investments reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Cigna Investments sold 788 Abiomed Inc shares in Q2 2022, an estimated $261K.
  • Cigna Investments first reported a position in Abiomed Inc in Q1 2017 and held it in 20 quarters.
  • Cigna Investments's Abiomed Inc position peaked at $589K in Q2 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Cigna Investments's 13F filing for Q2 2022, filed 15 Aug 2022.